title: Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes.
abstract: The formation of proteinaceous aggregates is a pathognomonic hallmark of several neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. To date, the final diagnostic for these diseases can only be achieved by immunostaining of post-mortem brain tissues with the commonly used congo red and Thioflavin T/S amyloid-dyes. The interest in developing amyloid-avid radioprobes to be used for protein aggregates imaging by positron emission tomography has grown substantialy, due to the promise in assisting diagnosis of these disorders. To this purpose, the present work describes the synthesis and characterization of four novel fluorinated styryl benzazole derivatives 1-4 by means of the Wittig reaction, as well as their in vitro evaluation as amyloid-probing agents. All compounds were obtained as mixtures of geometric E and Z isomers, with the preferable formation of the E isomer. Photoisomerization reactions allowed for the maximization of the minor Z isomers. The authentic 1-4E/Z isomers were isolated after purification by column chromatography under dark conditions. Profiting from the fluorescence properties of the different geometric isomers of 1-4, their binding affinities towards amyloid fibrils of insulin, α-synuclein and β-amyloid peptide were also measured. These compounds share similarities with Thioflavin T, interacting specifically with fibrillary species with a red-shift in the excitation wavelengths along with an increase in the fluorescence emission intensity. Apparent binding constants were determined and ranged between 1.22 and 23.96 μM(-1). The present data suggest that the novel fluorinated styryl benzazole derivatives may prove useful for the design of (18)F-labeled amyloid radioprobes.
authors.affiliation: Unidade de Ciências Químicas Radiofarmacêuticas, Instituto Tecnológico e Nuclear, Estrada Nacional 10, 2686 953 Sacavém, Portugal.
authors.forename: Goreti
authors.initials: G
authors.lastname: Ribeiro Morais
authors.forename: Hugo
authors.initials: H
authors.lastname: Vicente Miranda
authors.forename: Isabel C
authors.initials: IC
authors.lastname: Santos
authors.forename: Isabel
authors.initials: I
authors.lastname: Santos
authors.forename: Tiago F
authors.initials: TF
authors.lastname: Outeiro
authors.forename: Antonio
authors.initials: A
authors.lastname: Paulo
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis* / Q000378:metabolism; D000682:Amyloid / Q000032:analysis* / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism; D005453:Fluorescence; D005462:Fluorine Radioisotopes / Q000737:chemistry / Q000378:metabolism; D006571:Heterocyclic Compounds / Q000737:chemistry / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D007536:Isomerism; D008958:Models, Molecular; D010300:Parkinson Disease / Q000175:diagnosis* / Q000378:metabolism; D011485:Protein Binding; D013050:Spectrometry, Fluorescence; D051844:alpha-Synuclein / Q000378:metabolism
chemical_list: D000682:Amyloid; D016229:Amyloid beta-Peptides; D005462:Fluorine Radioisotopes; D006571:Heterocyclic Compounds; D007328:Insulin; D051844:alpha-Synuclein